Weibo Cai
#107,701
Most Influential Person Now
Researcher
Weibo Cai's AcademicInfluence.com Rankings
Weibo Caiengineering Degrees
Engineering
#3012
World Rank
#4026
Historical Rank
Biomedical Engineering
#112
World Rank
#114
Historical Rank
Weibo Caicomputer-science Degrees
Computer Science
#3975
World Rank
#4180
Historical Rank
Computer Graphics
#84
World Rank
#87
Historical Rank
Database
#1217
World Rank
#1283
Historical Rank
Download Badge
Engineering Computer Science
Weibo Cai's Degrees
- Bachelors Biomedical Engineering Tsinghua University
Why Is Weibo Cai Influential?
(Suggest an Edit or Addition)Weibo Cai's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. (2020) (1361)
- Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy (2008) (996)
- Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. (2006) (894)
- Applications of gold nanoparticles in cancer nanotechnology. (2008) (657)
- Nanoplatforms for targeted molecular imaging in living subjects. (2007) (513)
- Nanozyme: new horizons for responsive biomedical applications. (2019) (512)
- Multimodality Molecular Imaging of Tumor Angiogenesis (2008) (487)
- Biomedical applications of zinc oxide nanomaterials. (2013) (460)
- Graphene: a versatile nanoplatform for biomedical applications. (2012) (449)
- Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy. (2015) (423)
- Dual-Function Probe for PET and Near-Infrared Fluorescence Imaging of Tumor Vasculature (2007) (405)
- cRGD-functionalized, DOX-conjugated, and ⁶⁴Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. (2011) (377)
- Non-invasive, Multimodal Functional Imaging of the Intestine with Frozen Micellar Naphthalocyanines (2014) (334)
- Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. (2014) (324)
- Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy. (2017) (309)
- In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nanographene. (2012) (297)
- In vivo tumor targeting and image-guided drug delivery with antibody-conjugated, radiolabeled mesoporous silica nanoparticles. (2013) (292)
- NanoLuc: A Small Luciferase Is Brightening Up the Field of Bioluminescence. (2016) (279)
- PET of vascular endothelial growth factor receptor expression. (2006) (266)
- Quantitative PET Imaging of Tumor Integrin αvβ3 Expression with 18F-FRGD2 (2006) (252)
- Preparation and functionalization of graphene nanocomposites for biomedical applications (2013) (249)
- Scintillating Nanoparticles as Energy Mediators for Enhanced Photodynamic Therapy. (2016) (248)
- Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody (2007) (245)
- Molecular imaging and therapy of cancer with radiolabeled nanoparticles. (2009) (224)
- 64Cu-Labeled Tetrameric and Octameric RGD Peptides for Small-Animal PET of Tumor αvβ3 Integrin Expression (2007) (221)
- Engineering of inorganic nanoparticles as magnetic resonance imaging contrast agents. (2017) (216)
- Anti-Angiogenic Cancer Therapy Based on Integrin αvβ3 Antagonism (2006) (211)
- Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging (2008) (211)
- Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging. (2012) (208)
- DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury (2018) (208)
- Nanobody: The “Magic Bullet” for Molecular Imaging? (2014) (200)
- Biodegradable and Renal Clearable Inorganic Nanoparticles (2015) (199)
- Dual-modality optical and positron emission tomography imaging of vascular endothelial growth factor receptor on tumor vasculature using quantum dots (2008) (197)
- FeSe2‐Decorated Bi2Se3 Nanosheets Fabricated via Cation Exchange for Chelator‐Free 64Cu‐Labeling and Multimodal Image‐Guided Photothermal‐Radiation Therapy (2016) (193)
- Imaging of integrins as biomarkers for tumor angiogenesis. (2008) (191)
- In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene. (2012) (188)
- Cancer-targeted optical imaging with fluorescent zinc oxide nanowires. (2011) (184)
- Are quantum dots ready for in vivo imaging in human subjects? (2007) (182)
- Theranostic Nanoparticles (2014) (181)
- Hexamodal Imaging with Porphyrin‐Phospholipid‐Coated Upconversion Nanoparticles (2015) (177)
- Effective weight control via an implanted self-powered vagus nerve stimulation device (2018) (176)
- How molecular imaging is speeding up antiangiogenic drug development (2006) (175)
- Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy (2014) (174)
- Effective Wound Healing Enabled by Discrete Alternative Electric Fields from Wearable Nanogenerators (2018) (172)
- ImmunoPET: Concept, Design, and Applications. (2020) (171)
- HaloTag Technology: A Versatile Platform for Biomedical Applications (2015) (169)
- In vitro and In vivo Characterization of 64Cu-Labeled AbegrinTM, a Humanized Monoclonal Antibody against Integrin αvβ3 (2006) (167)
- Aptamer-based fluorescent biosensors. (2011) (166)
- Positron emission tomography imaging using radiolabeled inorganic nanomaterials. (2015) (165)
- 18F-labeled bombesin analogs for targeting GRP receptor-expressing prostate cancer. (2006) (163)
- Gold Nanorods Conjugated with Doxorubicin and cRGD for Combined Anticancer Drug Delivery and PET Imaging (2012) (163)
- Scavenging of reactive oxygen and nitrogen species with nanomaterials (2018) (157)
- Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models (2015) (154)
- Nanomedicine for targeted photothermal cancer therapy: where are we now? (2015) (151)
- Intrinsically Germanium‐69‐Labeled Iron Oxide Nanoparticles: Synthesis and In‐Vivo Dual‐Modality PET/MR Imaging (2014) (149)
- In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine (2015) (146)
- PET tracers based on Zirconium-89. (2011) (142)
- Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy (2018) (141)
- CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. (2014) (139)
- Tumor vasculature targeting and imaging in living mice with reduced graphene oxide. (2013) (133)
- Applications of gold nanoparticles in cancer nanotechnology. (2008) (132)
- Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab (2016) (131)
- A Thiol-Reactive 18F-Labeling Agent, N-[2-(4-18F-Fluorobenzamido)Ethyl]Maleimide, and Synthesis of RGD Peptide-Based Tracer for PET Imaging of αvβ3 Integrin Expression (2006) (131)
- Molecular Imaging with Single-Walled Carbon Nanotubes. (2009) (126)
- Positron emission tomography and nanotechnology: A dynamic duo for cancer theranostics☆ (2017) (126)
- PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody. (2007) (124)
- In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles (2015) (122)
- Biocompatibility and in vivo operation of implantable mesoporous PVDF-based nanogenerators. (2016) (121)
- Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles. (2016) (116)
- Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice (2018) (115)
- A new PET tracer specific for vascular endothelial growth factor receptor 2 (2007) (114)
- Magnetic Targeting of Nanotheranostics Enhances Cerenkov Radiation-Induced Photodynamic Therapy. (2018) (114)
- Chelator-free synthesis of a dual-modality PET/MRI agent. (2013) (114)
- Surface Engineering of Graphene-Based Nanomaterials for Biomedical Applications (2014) (112)
- Bioresponsive Polyoxometalate Cluster for Redox-Activated Photoacoustic Imaging-Guided Photothermal Cancer Therapy. (2017) (112)
- Positron Emission Tomography Imaging of CD105 Expression with a 64Cu-Labeled Monoclonal Antibody: NOTA Is Superior to DOTA (2011) (111)
- Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET (2008) (108)
- microPET of Tumor Integrin αvβ3 Expression Using 18F-Labeled PEGylated Tetrameric RGD Peptide (18F-FPRGD4) (2007) (108)
- Multimodality imaging of the HER-kinase axis in cancer (2007) (105)
- Imaging with Raman spectroscopy. (2010) (104)
- Ceria Nanoparticles Meet Hepatic Ischemia‐Reperfusion Injury: The Perfect Imperfection (2019) (104)
- Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics. (2018) (102)
- 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of αvβ3 integrin expression (2007) (101)
- VEGF121-Conjugated Mesoporous Silica Nanoparticle: A Tumor Targeted Drug Delivery System (2014) (101)
- Tumor-targeted drug delivery with aptamers. (2011) (101)
- Multimodality molecular imaging of glioblastoma growth inhibition with vasculature-targeting fusion toxin VEGF121/rGel. (2007) (99)
- Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. (2006) (98)
- Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism. (2006) (96)
- Renal‐Clearable PEGylated Porphyrin Nanoparticles for Image‐Guided Photodynamic Cancer Therapy (2017) (95)
- Intrinsically radiolabeled nanoparticles: an emerging paradigm. (2014) (95)
- Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. (2018) (93)
- Near-Infrared Fluorescence Imaging of Tumor Integrin αvβ3 Expression with Cy7-Labeled RGD Multimers (2006) (93)
- Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. (2007) (92)
- Photoacoustic imaging. (2020) (91)
- In Vivo Tumor Vasculature Targeted PET/NIRF Imaging with TRC105(Fab)-Conjugated, Dual-Labeled Mesoporous Silica Nanoparticles (2014) (90)
- Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles. (2013) (90)
- Non-invasive cell tracking in cancer and cancer therapy. (2010) (87)
- CARM1 Methylates Chromatin Remodeling Factor BAF155 to Enhance Tumor Progression and Metastasis. (2016) (86)
- Harnessing the Power of Nanotechnology for Enhanced Radiation Therapy. (2017) (85)
- 89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer (2017) (83)
- Dual-Modality Positron Emission Tomography/Optical Image-Guided Photodynamic Cancer Therapy with Chlorin e6-Containing Nanomicelles. (2016) (82)
- Positron Emission Tomography Image-Guided Drug Delivery: Current Status and Future Perspectives (2014) (82)
- Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging. (2013) (82)
- ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-small Cell Lung Cancer. (2017) (82)
- Theranostic Unimolecular Micelles Based on Brush-Shaped Amphiphilic Block Copolymers for Tumor-Targeted Drug Delivery and Positron Emission Tomography Imaging (2014) (82)
- (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression. (2007) (81)
- Molecular imaging with nucleic acid aptamers. (2011) (81)
- 44Sc: An Attractive Isotope for Peptide-Based PET Imaging (2014) (80)
- Molecular imaging with SERS-active nanoparticles. (2011) (80)
- Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice (2007) (79)
- Semiconductor quantum dots for in vivo imaging. (2007) (79)
- Plumbagin, a medicinal plant (lumbago zeylanica)‐derived 1,4‐naphthoquinone, inhibits growth and metastasis of human prostate cancer PC‐3M‐luciferase cells in an orthotopic xenograft mouse model (2013) (78)
- A Melanin‐Based Natural Antioxidant Defense Nanosystem for Theranostic Application in Acute Kidney Injury (2019) (78)
- Positron emission tomography imaging of CD105 expression during tumor angiogenesis (2011) (77)
- Noninvasive PET Imaging of T cells. (2018) (76)
- Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105 (2011) (75)
- Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery. (2015) (75)
- Collagen mimetic dendrimers. (2002) (75)
- 52Mn Production for PET/MRI Tracking Of Human Stem Cells Expressing Divalent Metal Transporter 1 (DMT1) (2015) (74)
- Red fluorescent zinc oxide nanoparticle: a novel platform for cancer targeting. (2015) (74)
- Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme (2008) (73)
- Molecular Imaging of Immunotherapy Targets in Cancer (2016) (73)
- Efficient Uptake of 177 Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. (2018) (72)
- Novel Preparation Methods of (52)Mn for ImmunoPET Imaging. (2015) (70)
- Reassembly of 89Zr‐Labeled Cancer Cell Membranes into Multicompartment Membrane‐Derived Liposomes for PET‐Trackable Tumor‐Targeted Theranostics (2018) (70)
- Quantitative PET Imaging of VEGF Receptor Expression (2008) (68)
- Radiotheranostics in Cancer Diagnosis and Management. (2018) (68)
- Matching the Decay Half-Life with the Biological Half-Life: ImmunoPET Imaging with 44Sc-Labeled Cetuximab Fab Fragment (2014) (68)
- In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. (2006) (67)
- Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography (2008) (67)
- Multimodality imaging of breast cancer experimental lung metastasis with bioluminescence and a monoclonal antibody dual-labeled with 89Zr and IRDye 800CW. (2012) (67)
- Selenium‐Doped Carbon Quantum Dots Act as Broad‐Spectrum Antioxidants for Acute Kidney Injury Management (2020) (66)
- Self-Activated Electrical Stimulation for Effective Hair Regeneration via a Wearable Omnidirectional Pulse Generator. (2019) (66)
- PET imaging of acute and chronic inflammation in living mice (2007) (64)
- Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies (2016) (64)
- Positron emission tomography imaging of prostate cancer (2010) (64)
- Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications. (2018) (63)
- VEGFR targeting leads to significantly enhanced tumor uptake of nanographene oxide in vivo. (2015) (63)
- Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy. (2007) (62)
- Ultra-small iron-gallic acid coordination polymer nanoparticles for chelator-free labeling of 64Cu and multimodal imaging-guided photothermal therapy. (2017) (62)
- Tumor vasculature targeting: a generally applicable approach for functionalized nanomaterials. (2014) (62)
- Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free 64Cu-Labeling and Imaging-Guided Enhanced Radiotherapy of Cancer. (2017) (61)
- Molecular Imaging of Pancreatic Cancer with Antibodies (2015) (59)
- Re-assessing the enhanced permeability and retention effect in peripheral arterial disease using radiolabeled long circulating nanoparticles. (2016) (59)
- Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles. (2016) (58)
- Chelator-Free Radiolabeling of Nanographene: Breaking the Stereotype of Chelation. (2017) (57)
- Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab. (2012) (57)
- Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes. (2017) (56)
- A porphyrin-PEG polymer with rapid renal clearance. (2016) (56)
- Quantum dot-based nanoprobes for in vivo targeted imaging. (2013) (56)
- Noninvasive de novo imaging of human embryonic stem cell-derived teratoma formation. (2009) (55)
- Surfactant‐Stripped Frozen Pheophytin Micelles for Multimodal Gut Imaging (2016) (55)
- Wafer-scale heterostructured piezoelectric bio-organic thin films (2021) (55)
- A Novel Fusion of ALT-803 (Interleukin (IL)-15 Superagonist) with an Antibody Demonstrates Antigen-specific Antitumor Responses* (2016) (55)
- Multimodality imaging of nitric oxide and nitric oxide synthases. (2009) (53)
- Applications of aptamers in targeted imaging: state of the art. (2015) (53)
- CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody (2016) (52)
- Chirality-driven transportation and oxidation prevention by chiral selenium nanoparticles. (2019) (52)
- Molecular Imaging of Proteases in Cancer. (2009) (52)
- Long circulating reduced graphene oxide-iron oxide nanoparticles for efficient tumor targeting and multimodality imaging. (2016) (52)
- Aptamers as therapeutics in cardiovascular diseases. (2011) (52)
- Study of Long-Term Biocompatibility and Bio-Safety of Implantable Nanogenerators. (2018) (51)
- Multimodality tumor imaging targeting integrin alphavbeta3. (2005) (51)
- Chelator-Free Labeling of Layered Double Hydroxide Nanoparticles for in Vivo PET Imaging (2015) (50)
- Multimodality Imaging of Integrin αvβ3 Expression (2011) (50)
- Imaging of Abdominal Aortic Aneurysm: the present and the future. (2010) (50)
- Positron Emission Tomography Imaging of Poststroke Angiogenesis (2009) (49)
- Multimodality Imaging Agents with PET as the Fundamental Pillar. (2019) (49)
- Multimodality molecular imaging of CD105 (Endoglin) expression. (2011) (49)
- Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein (2008) (48)
- Integrin αvβ3 Antagonists for Anti-Angiogenic Cancer Treatment (2007) (48)
- Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry (2015) (47)
- ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW. (2012) (47)
- PET imaging of CD105/endoglin expression with a 61/64Cu-labeled Fab antibody fragment (2013) (47)
- DNA nanomaterials for preclinical imaging and drug delivery. (2016) (46)
- Metal-assisted assembly and stabilization of collagen-like triple helices. (2004) (45)
- Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen (2008) (45)
- Targeting CD146 with a 64Cu-labeled antibody enables in vivo immunoPET imaging of high-grade gliomas (2015) (45)
- Non-Invasive PET Imaging of EGFR Degradation Induced by a Heat Shock Protein 90 Inhibitor (2008) (44)
- Quantum dot-NanoLuc bioluminescence resonance energy transfer enables tumor imaging and lymph node mapping in vivo. (2016) (44)
- Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. (2012) (44)
- PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow (2013) (43)
- microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4). (2007) (43)
- Immuno-PET of Tissue Factor in Pancreatic Cancer (2012) (43)
- New radiotracers for imaging of vascular targets in angiogenesis-related diseases. (2014) (41)
- A highly hemocompatible erythrocyte membrane-coated ultrasmall selenium nanosystem for simultaneous cancer radiosensitization and precise antiangiogenesis. (2018) (40)
- Smart H2S‐Triggered/Therapeutic System (SHTS)‐Based Nanomedicine (2019) (40)
- Engineering of radiolabeled iron oxide nanoparticles for dual-modality imaging. (2016) (39)
- Multimodality Imaging of IL-18–Binding Protein-Fc Therapy of Experimental Lung Metastasis (2008) (39)
- Chapter 7. Molecular imaging of tumor vasculature. (2008) (38)
- Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease. (2016) (38)
- Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview. (2017) (38)
- Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine. (2018) (38)
- Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging. (2017) (37)
- Self-amplified Photodynamic Therapy through 1O2-mediated In Situ Internalization of Photosensitizers from a Ppa-bearing Block Copolymer. (2019) (37)
- Antibody and fragment-based PET imaging of CTLA-4+ T-cells in humanized mouse models. (2019) (37)
- Implanted Battery-Free Direct-Current Micro-Power Supply from in Vivo Breath Energy Harvesting. (2018) (36)
- Molecular imaging of β-cells: diabetes and beyond. (2019) (36)
- Combination of integrin siRNA and irradiation for breast cancer therapy. (2006) (36)
- Positron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody. (2012) (36)
- Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers. (2006) (36)
- In vivo near-infrared fluorescence imaging of CD105 expression during tumor angiogenesis (2011) (36)
- Positron Emission Tomography Imaging of Atherosclerosis (2013) (36)
- Dual-Targeted Molecular Imaging of Cancer (2018) (36)
- Positron emission tomography imaging of tumor angiogenesis with a (61/64)Cu-labeled F(ab')(2) antibody fragment. (2013) (35)
- Photo-Enhanced Singlet Oxygen Generation of Prussian Blue-Based Nanocatalyst for Augmented Photodynamic Therapy (2018) (35)
- CD146‐Targeted Multimodal Image‐Guided Photoimmunotherapy of Melanoma (2019) (35)
- Intrinsic and Stable Conjugation of Thiolated Mesoporous Silica Nanoparticles with Radioarsenic. (2017) (35)
- Site-Specific Immuno-PET Tracer to Image PD-L1. (2019) (34)
- Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature. (2015) (34)
- Intrathecal Administration of Nanoclusters for Protecting Neurons against Oxidative Stress in Cerebral Ischemia/Reperfusion Injury. (2019) (34)
- Multifunctional Artificial Artery from Direct 3D Printing with Built‐In Ferroelectricity and Tissue‐Matching Modulus for Real‐Time Sensing and Occlusion Monitoring (2020) (33)
- Molecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review. (2013) (33)
- Aptamer-Conjugated Framework Nucleic Acids for the Repair of Cerebral Ischemia-Reperfusion Injury. (2019) (33)
- In Vivo Imaging of RNA Interference (2010) (33)
- Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha (2008) (32)
- Multimodality tumor imaging targeting integrin α v β 3 (2005) (32)
- PET Imaging of Abdominal Aortic Aneurysm with 64Cu-Labeled Anti-CD105 Antibody Fab Fragment (2015) (32)
- Anatomical and molecular imaging of skin cancer (2008) (32)
- Evolution of Zinc Oxide Nanostructures through Kinetics Control. (2011) (32)
- Radiolabeled polyoxometalate clusters: Kidney dysfunction evaluation and tumor diagnosis by positron emission tomography imaging. (2018) (31)
- Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression. (2008) (31)
- Chelator-Free Labeling of Metal Oxide Nanostructures with Zirconium-89 for Positron Emission Tomography Imaging. (2017) (31)
- Sulfoxide‐Containing Polymer‐Coated Nanoparticles Demonstrate Minimal Protein Fouling and Improved Blood Circulation (2020) (31)
- A self-powered implantable and bioresorbable electrostimulation device for biofeedback bone fracture healing (2021) (31)
- Surfactant-stripped naphthalocyanines for multimodal tumor theranostics with upconversion guidance cream. (2017) (31)
- ImmunoPET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer with a Dual-Labeled Bispecific Antibody Fragment. (2017) (31)
- Integrin alpha v beta 3 antagonists for anti-angiogenic cancer treatment. (2007) (30)
- High Yield Production and Radiochemical Isolation of Isotopically Pure Arsenic-72 and Novel Radioarsenic Labeling Strategies for the Development of Theranostic Radiopharmaceuticals. (2016) (30)
- Radionuclide-Activated Nanomaterials and Their Biomedical Applications. (2019) (30)
- HaloTag: a novel reporter gene for positron emission tomography. (2011) (30)
- Imaging of Induced Pluripotent Stem Cells: From Cellular Reprogramming to Transplantation. (2011) (29)
- 18F-Labeled mini-PEG spacered RGD dimer (18F-FPRGD2): Synthesis and microPET imaging of {alpha}v{beta}3 integrin expression (2007) (29)
- PET Imaging of Receptor Tyrosine Kinases in Cancer (2018) (29)
- Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies (2017) (29)
- α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colon Cancer Xenografts (2017) (28)
- Facile Preparation of Multifunctional WS2 /WOx Nanodots for Chelator-Free 89 Zr-Labeling and In Vivo PET Imaging. (2016) (28)
- Evaluation of the biological activities of the IL‐15 superagonist complex, ALT‐803, following intravenous versus subcutaneous administration in murine models (2018) (28)
- Size-Optimized Ultrasmall Porous Silica Nanoparticles Depict Vasculature-Based Differential Targeting in Triple Negative Breast Cancer. (2019) (28)
- Nanomedicines for Renal Management: From Imaging to Treatment. (2020) (28)
- Radiomanganese PET Detects Changes in Functional β-Cell Mass in Mouse Models of Diabetes (2017) (28)
- Intrinsically Zirconium-89 Labeled Gd2 O2 S:Eu Nanoprobes for In Vivo Positron Emission Tomography and Gamma-Ray-Induced Radioluminescence Imaging. (2016) (28)
- In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem (2018) (28)
- ImmunoPET of tissue factor expression in triple-negative breast cancer with a radiolabeled antibody Fab fragment (2015) (28)
- Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer (2017) (27)
- Targeting and microenvironment-improving of phenylboronic acid-decorated soy protein nanoparticles with different sizes to tumor (2019) (27)
- Protein-Protein Interactions - Computational and Experimental Tools (2012) (27)
- Radiolabeled γ-AApeptides: a new class of tracers for positron emission tomography. (2012) (26)
- In Vivo Bioluminescence Tumor Imaging of RGD Peptide-modified Adenoviral Vector Encoding Firefly Luciferase Reporter Gene (2007) (26)
- Pharmacokinetic Issues of Imaging with Nanoparticles: Focusing on Carbon Nanotubes and Quantum Dots (2013) (26)
- Noninvasive Imaging and Quantification of Radiotherapy-Induced PD-L1 Upregulation with 89Zr-Df-Atezolizumab. (2019) (26)
- PET and SPECT imaging of melanoma: the state of the art (2017) (25)
- PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab (2016) (25)
- A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression. (2006) (25)
- Design and Applications of Bispecific Heterodimers: Molecular Imaging and beyond (2014) (25)
- CD38 as a PET Imaging Target in Lung Cancer. (2017) (24)
- HPMA-based star polymer biomaterials with tuneable structure and biodegradability tailored for advanced drug delivery to solid tumours. (2019) (24)
- ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab (2018) (24)
- A tumor-targeted polymer theranostics platform for positron emission tomography and fluorescence imaging. (2017) (24)
- Internally Responsive Nanomaterials for Activatable Multimodal Imaging of Cancer (2020) (24)
- Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence (2013) (24)
- Peptoid and Positron Emission Tomography: an Appealing Combination. (2011) (23)
- Uptake and retention of manganese contrast agents for PET and MRI in the rodent brain. (2016) (23)
- Dual Targeting of Tissue Factor and CD105 for Preclinical PET Imaging of Pancreatic Cancer (2016) (23)
- In a "nutshell": intrinsically radio-labeled quantum dots. (2012) (23)
- Production and in vivo PET/CT imaging of the theranostic pair 132/135La (2019) (23)
- Efficient renal clearance of DNA tetrahedron nanoparticles enables quantitative evaluation of kidney function (2018) (23)
- ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors. (2016) (22)
- Intrinsically Zirconium-89-Labeled Manganese Oxide Nanoparticles for In Vivo Dual-Modality Positron Emission Tomography and Magnetic Resonance Imaging. (2018) (22)
- Multimodality imaging of CXCR4 in cancer: current status towards clinical translation. (2013) (22)
- Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth (2019) (22)
- Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105. (2013) (21)
- Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles (2017) (21)
- Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy. (2018) (21)
- The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model (2008) (21)
- General synthesis of silica-based yolk/shell hybrid nanomaterials and in vivo tumor vasculature targeting (2018) (21)
- Prevention of Hepatic Ischemia-Reperfusion Injury by Carbohydrate-Derived Nanoantioxidants. (2020) (21)
- Astrocyte-Neuron Signaling in Synaptogenesis (2021) (20)
- Non-invasive imaging of human embryonic stem cells. (2010) (20)
- PET of follicle-stimulating hormone receptor: broad applicability to cancer imaging. (2015) (20)
- Intrinsic radiolabeling of Titanium-45 using mesoporous silica nanoparticles (2017) (20)
- Imaging gene expression in live cells and tissues. (2011) (20)
- PET of c-Met in Cancer with 64Cu-Labeled Hepatocyte Growth Factor (2015) (20)
- Open‐Shell Nanosensitizers for Glutathione Responsive Cancer Sonodynamic Therapy (2022) (20)
- A “Missile‐Detonation” Strategy to Precisely Supply and Efficiently Amplify Cerenkov Radiation Energy for Cancer Theranostics (2019) (19)
- ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer (2016) (19)
- Preparation and in vivo characterization of 51MnCl2 as PET tracer of Ca2+ channel-mediated transport (2017) (19)
- Effect of ultrasonic agitation during the activation process on the microstructure and corrosion resistance of electroless Ni-W-P coatings on AZ91D magnesium alloy (2019) (19)
- Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models. (2018) (19)
- Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents (2017) (18)
- Positron emission tomography imaging of CD105 expression in a rat myocardial infarction model with (64)Cu-NOTA-TRC105. (2013) (18)
- Pravastatin stimulates angiogenesis in a murine hindlimb ischemia model: a positron emission tomography imaging study with (64)Cu-NOTA-TRC105. (2013) (18)
- Noninvasive Evaluation of CD20 Expression Using 64Cu-Labeled F(ab′)2 Fragments of Obinutuzumab in Lymphoma (2020) (17)
- Intraoperative targeted optical imaging: a guide towards tumor-free margins in cancer surgery. (2014) (17)
- Ultrasmall Porous Silica Nanoparticles with Enhanced Pharmacokinetics for Cancer Theranostics. (2021) (16)
- Dual-labeled pertuzumab for multimodality image-guided ovarian tumor resection. (2019) (16)
- “Albumin Hitchhiking” with an Evans Blue Analog for Cancer Theranostics (2018) (16)
- Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond (2022) (16)
- Tissue Factor‐Targeted ImmunoPET Imaging and Radioimmunotherapy of Anaplastic Thyroid Cancer (2020) (15)
- In vivo characterization of PD-L1 expression in breast cancer by immuno-PET with 89Zr-labeled avelumab. (2020) (15)
- Antibody-based imaging of HER-2: moving into the clinic. (2013) (15)
- 86/90Y-labeled monoclonal antibody targeting tissue factor for pancreatic cancer theranostics. (2020) (15)
- Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody (2017) (15)
- ImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr‐Df‐ALT‐836 (2017) (15)
- PET imaging of macrophages in cardiovascular diseases. (2020) (15)
- ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer (2016) (15)
- Fluorobenzamido)Ethyl)Maleimide, and Synthesis of RGD Peptide-Based Tracer for PET Imaging of a v b 3 Integrin Expression (2006) (14)
- CD38‐Targeted Theranostics of Lymphoma with 89Zr/177Lu‐Labeled Daratumumab (2021) (14)
- Antibody‐Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases (2018) (14)
- Self‐Amplified Photodynamic Therapy through the 1 O 2 ‐Mediated Internalization of Photosensitizers from a Ppa‐Bearing Block Copolymer (2020) (13)
- HER2-targeted multimodal imaging of anaplastic thyroid cancer. (2019) (13)
- ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer. (2017) (13)
- Chemical Factory‐Guaranteed Enhanced Chemodynamic Therapy for Orthotopic Liver Cancer (2022) (13)
- Development and characterization of CD54-targeted immunoPET imaging in solid tumors (2020) (13)
- Evaluation of two novel 64Cu-labeled RGD peptide radiotracers for enhanced PET imaging of tumor integrin αvβ3 (2015) (13)
- [nat/44Sc(pypa)]-: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate. (2020) (13)
- Moving Beyond the Pillars of Cancer Treatment: Perspectives From Nanotechnology (2020) (13)
- Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121. (2012) (13)
- Intracellular signaling pathway in dendritic cells and antigen transport pathway in vivo mediated by an OVA@DDAB/PLGA nano-vaccine (2021) (12)
- Long-term in vivo operation of implanted cardiac nanogenerators in swine. (2021) (12)
- 64Cu-Labeled tetrameric and octameric RGD peptides for microPET imaging of tumor {alpha}v{beta}3 integrin expression (2007) (12)
- 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. (2018) (12)
- Facile and efficient assembly of collagen-like triple helices on a TRIS scaffold. (2007) (12)
- Surfactant-Stripped Pheophytin Micelles for Multimodal Tumor Imaging and Photodynamic Therapy. (2019) (11)
- Molecular imaging of insulin-like growth factor 1 receptor in cancer. (2012) (11)
- ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using 64Cu-labeled daratumumab. (2019) (11)
- Multimodality imaging of RNA interference. (2013) (11)
- In vitro study of enhanced photodynamic cancer cell killing effect by nanometer-thick gold nanosheets (2020) (11)
- Radionuclide-Based Imaging of Breast Cancer: State of the Art (2021) (11)
- Intrinsically 89Zr-labeled Gd2O2S:Eu nanophosphors with high in vivo stability for dual-modality imaging. (2016) (10)
- ImmunoPET Imaging of TIM‐3 in Murine Melanoma Models (2020) (10)
- Antioxidant and C5a-blocking strategy for hepatic ischemia–reperfusion injury repair (2021) (9)
- ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma (2021) (9)
- Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity. (2013) (9)
- Engineering in Translational Medicine (2014) (9)
- Spherical nucleic acids: Organized nucleotide aggregates as versatile nanomedicine (2021) (9)
- HaloTag as a reporter gene: positron emission tomography imaging with (64)Cu-labeled second generation HaloTag ligands. (2013) (9)
- A Switchable Site-Specific Antibody Conjugate. (2018) (9)
- Harnessing the Power of Molecular Imaging for Precision Medicine (2016) (8)
- Engineering biocompatible TeSex nano-alloys as a versatile theranostic nanoplatform (2020) (8)
- Spatiotemporal Distribution of Agrin after Intrathecal Injection and Its Protective Role in Cerebral Ischemia/Reperfusion Injury (2019) (8)
- In vivo targeting and imaging of tumor vasculature with radiolabeled, antibody-conjugated nano-graphene (2012) (8)
- Novel Small Molecule Probes for Metastatic Melanoma. (2017) (8)
- microPET of Tumor Integrin a v b 3 Expression Using 18 F-Labeled PEGylated Tetrameric RGD Peptide ( 18 F-FPRGD 4 ) (2007) (8)
- ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models. (2021) (8)
- The New Science of Protein Mimetics (2003) (8)
- ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer (2021) (8)
- 64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma (2021) (8)
- Nanoplatforms for Targeted Molecular Imaging in Living (2007) (8)
- Immuno-PET imaging of VEGFR-2 expression in prostate cancer with 89Zr-labeled ramucirumab. (2019) (8)
- Dynamic PET imaging with ultra-low-activity of 18F-FDG: unleashing the potential of total-body PET (2021) (8)
- The bold legacy of Emil Fischer (2003) (8)
- Generation and Screening of Monoclonal Antibodies for ImmunoPET Imaging of IGF1R in Prostate Cancer (2014) (8)
- The new era of cancer immunotherapy: what can molecular imaging do to help? (2017) (7)
- Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review (2021) (7)
- PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617 (2022) (7)
- Total-Body PET Imaging for up to 30 Days After Injection of 89Zr-Labeled Antibodies (2019) (7)
- ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. (2018) (7)
- Responsive hyaluronic acid-gold cluster hybrid nanogel theranostic systems. (2020) (7)
- Nanostructured polyvinylpyrrolidone-curcumin conjugates allowed for kidney-targeted treatment of cisplatin induced acute kidney injury (2022) (6)
- Nanoparticles as Radiopharmaceutical Vectors (2019) (6)
- Smaller Agents for Larger Therapeutic Indices: Nanoscale Brachytherapy with 177Lu-Labeled Gold Nanoparticles (2016) (6)
- American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2015) e-Century Publishing Corporation. (2015) (6)
- Radio-nanomaterials for biomedical applications: state of the art (2016) (6)
- Auger electron-based targeted radioimmunotherapy with 58mCo, a feasibility study (2016) (6)
- First clinical experience of 106 cm, long axial field-of-view (LAFOV) PET/CT: an elegant balance between standard axial (23 cm) and total-body (194 cm) systems (2021) (6)
- Cancer Theranostics with Carbon-Based Nanoplatforms (2014) (6)
- Imaging the Biodistribution and Performance of Transplanted Stem Cells with PET (2016) (5)
- Cancer theranostics with 64Cu/177Lu-loaded liposomes (2016) (5)
- Erratum to: Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence (2013) (5)
- Synergistically enhanced tumor uptake via dual-targeting of CD105 and EGFR using a “click” heterodimer (2015) (5)
- Positron emission tomography: state of the art. (2014) (5)
- Original Article Positron emission tomography and near-infrared fluores- cence imaging of vascular endothelial growth factor with dual-labeled bevacizumab (2012) (5)
- Harnessing DNA for Immunotherapy: Cancer, Infectious Diseases, and Beyond (2022) (4)
- In a “ nutshell ” : intrinsically radiolabeled quantum dots (2012) (4)
- Deep learning convolutional neural network (DLCNN): unleashing the potential of 18F-FDG PET/CT in lymphoma. (2021) (4)
- Spleen‐Targeted Glabridin‐Loaded Nanoparticles Regulate Polarization of Monocyte/Macrophage (Mo/Mφ) for the Treatment of Cerebral Ischemia‐Reperfusion Injury (2022) (4)
- Nanobody theranostics on the horizon. (2022) (4)
- Spectral Computed Tomography with Inorganic Nanomaterials: State-of-the-Art. (2022) (4)
- Engineering Upconversion Nanoparticles for Biomedical Imaging and Therapy (2014) (4)
- In Vivo Tumor Targeting and Drug Delivery with Mesoporous Silica Nanoparticles (2013) (4)
- Catalytic radiosensitization: Insights from materials physicochemistry. (2022) (4)
- PET with a 68Ga-Labeled FAPI Dimer: Moving Toward Theranostics (2021) (4)
- First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers (2021) (4)
- Next-Generation Molecular Imaging of Thyroid Cancer (2021) (4)
- Seeing is believing: molecular imaging in living subjects. (2010) (3)
- DNMT3B-mediated FAM111B methylation promotes papillary thyroid tumor glycolysis, growth and metastasis (2022) (3)
- Positron Emission Tomography Imaging of Intrinsically Titanium-45 Radiolabeled Mesoporous Silica Nanoparticles (2016) (3)
- Labeling of Erythrocytes by Porphyrin-Phospholipid. (2020) (3)
- In vivo tumor targeting of CD146 with antibody-conjugated hollow mesoporous silica nanoparticles (2015) (3)
- Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105. (2020) (3)
- WE-C-217BCD-06: In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene. (2012) (3)
- New wine in old bottles: 68Ga-PSMA-11 PET/CT reveals COVID-19 in patients with prostate cancer. (2021) (3)
- 64Cu-Labeled Aptamers for Tumor-Targeted Radionuclide Delivery. (2019) (3)
- Kalasalingam Academy of Research and Education) (2014) (3)
- Supplemental Information CARM 1 Methylates Chromatin Remodeling Factor BAF 155 to Enhance Tumor Progression and Metastasis (2013) (3)
- Engineering of Mesoporous Silica Nanoparticles for In Vivo Cancer Imaging and Therapy (2014) (3)
- Engineering Carbon Nanomaterials for Stem Cell-Based Tissue Engineering (2014) (3)
- Single-Domain Antibody Theranostics on the Horizon (2022) (2)
- VEGFR-targeted drug delivery in vivo with mesoporous silica nanoparticles (2014) (2)
- Iron oxide decorated MoS2 nanosheets for chelator-free radiolabeling and multimodal image-guided photothermal therapy (2015) (2)
- Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond (2022) (2)
- microPET Imaging of tumor {alpha}v{beta}3 integrin expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) (2007) (2)
- Probing the impact of isoflurane on acute pancreatic function with 52Mn-PET (2016) (2)
- A multifunctional CuS@MSN nanoplatform for tumor targeted PET imaging, drug delivery, and photothermal therapy (2014) (2)
- Exogenous Radionanomedicine: Inorganic Nanomaterials (2018) (2)
- In Vivo Imaging of Inflammation and Infection (2018) (2)
- In Vivo Molecular Imaging with Quantum Dots: Toward Multimodality and Theranostics (2015) (2)
- Scaffold Assembly of Collagen-Like Triple Helices at the C-Terminus (2007) (2)
- ImmunoPET of CD38 with a radiolabeled nanobody: promising for clinical translation (2021) (2)
- Biological Activities of IL-15 superagonist - IL-15 Mutein:IL-15RaFc complex following Intravenous or Subcutaneous Administration (2017) (2)
- Cerenkov Radiation-Induced Photodynamic Therapy Amplified by Magnetic Nanotheranostics (2019) (2)
- Peptides for Small-Animal PET of Tumor a v b 3 Integrin Expression (2007) (2)
- Line Segment Matching Fusing Local Gradient Order and Non-Local Structure Information (2021) (2)
- In vivo tumor vasculature targeting and PET imaging with reduced graphene oxide (2013) (2)
- Biologically active Camellia oleifera protein nanoparticles for improving the tumor microenvironment and drug delivery. (2020) (2)
- Zirconium-89 radiolabeled hollow ferulic acid nanostructure for PET imaging guided acute kidney injury therapy (2019) (2)
- Positron emission tomography imaging of CD 105 expression in a rat myocardial infarction model with 64 Cu-NOTA-TRC 105 (2013) (2)
- American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2011) e-Century Publishing Corporation. (2011) (2)
- Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence (2013) (2)
- Theranostics of lymphoma with 89Zr- and 177Lu-labeled daratumumab (2018) (2)
- Head-to-Head Comparison of Neck 18F-FDG PET/MR and PET/CT in the Diagnosis of Differentiated Thyroid Carcinoma Patients after Comprehensive Treatment (2021) (2)
- Vasculature-based differential tumor uptake of radiolabeled Ultrasmall Mesoporous Silica Nanoparticles in breast cancers models (2018) (1)
- Production, separation and labeling of 45Ti (2013) (1)
- Beamer: Stage-Aware Coflow Scheduling to Accelerate Hyper-Parameter Tuning in Deep Learning Clusters (2022) (1)
- Aptamers: versatile agents for biomedical applications. (2011) (1)
- Manganese ions chelated melanin ultra-small nanostructure for PET/MR bimodal imaging-guided acute kidney injury therapy (2019) (1)
- Imaging and therapy of diabetes: State of the art. (2019) (1)
- TH-EF-207A-02: Imaging Pancreatic Î2 -Cell Function with 51/52Mn-PET. (2016) (1)
- Radiochemistry for positron emission tomography. (2011) (1)
- PET imaging of VEGF receptor expression after experimental focal stroke (2008) (1)
- PET of CD105 expression with a 61/64Cu-labeled Fab antibody fragment (2013) (1)
- Editorial [Hot Topic: Aptamers: Versatile Agents for Biomedical Applications (Guest Editor: Weibo Cai)] (2011) (1)
- 800CW Dye and 89Zr Dual-labeled Antibody for the PET/NIRF/Cerenkov Multi-modality Imaging of ICAM-1 (CD54) in Pancreatic Cancer (2019) (1)
- Tumor targeted drug delivery with hollow mesoporous silica nanoparticles (2014) (1)
- Production, isolation, and application of 72As for immunoPET (2013) (1)
- Antibody-Based Imaging and Therapy for Precision Medicine. (2022) (1)
- ImmunoPET of the differential expression of CD146 in breast cancer. (2021) (1)
- DNA origami nanostructures can exhibit preferential renal uptake and alleviate acute kidney injury (2018) (1)
- Theranostic Nanoparticles for Photothermal Therapy of Cancer (2017) (1)
- Molecular Imaging: Intrinsically Radiolabeled Nanoparticles: An Emerging Paradigm (Small 19/2014) (2014) (1)
- Launch of the american journal of nuclear medicine and molecular imaging. (2011) (1)
- PEGylated Tetrameric RGD Peptide (18F-FPRGD4) (2014) (1)
- Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology. (2022) (1)
- Engineering CpG-ASO-Pt-Loaded Macrophages (CAP@M) for Synergistic Chemo-/Gene-/Immuno-Therapy (2022) (1)
- RGD Peptide-Labeled Quantum Dots for Integrin α v β 3 Targeting (2006) (1)
- One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine? (2018) (1)
- PET imaging of c-Met in cancer with 64Cu-labeled hepatocyte growth factor (2015) (1)
- Chelator-free 89Zr-labeling of Gd2O2S:Eu nanoparticles for multimodal in vivo imaging (2016) (1)
- Highlights from the latest articles in nano-oncology. (2015) (1)
- Dynamic PET imaging of renal clearable gold nanoparticles (2016) (1)
- Safety and dosimetry evaluation of radioimmunotherapy using 177Lu-labeled antibodies in lymphoma (2019) (1)
- Dual-labeled pertuzumab for multimodality preoperative and intraoperative imaging of ovarian cancer (2019) (1)
- Facile synthesis of 69Ge-labeled nanoparticles for dual-modality PET/MRI (2014) (1)
- Engineering of intrinsically zirconium-89 radiolabeled self-destructing mesoporous silica nanostructures for in vivo tumor vasculature targeting (2016) (1)
- Enhancing Photothermal Therapy Efficacy by In Situ Self-Assembly in Glioma. (2022) (1)
- Renal-Accumulating Selenium-Doped Carbon Quantum Dots Treat Acute Kidney Injury in Mice. (2019) (1)
- WE-C-217BCD-04: Multimodality Imaging of Breast Cancer Experimental Lung Metastasis. (2012) (1)
- Immuno-PET Imaging of the VEGFR-2 Expression in Prostate Cancer Using 89Zr-labeled Ramucirumab (2019) (1)
- Hybrid Nanomaterials : Design, Synthesis, and Biomedical Applications (2016) (1)
- Imaging CTLA-4+ T-cells in humanized mouse models (2019) (1)
- Integrin AvB3-Targeted Radioimmunotherapy of Glioblastoma (2008) (1)
- In Vivo Imaging of Protein-Protein Interactions (2012) (1)
- ImmunoPET: The Future of Response Evaluation for Cancer Immunotherapy (2019) (1)
- Recent biomedical advances enabled by HaloTag technology (2022) (1)
- Editorial: PET tracers based on nonstandard radionuclides. (2011) (1)
- In vivo tumor vasculature targeting and imaging with VEGF-conjugated nanographene oxide (2014) (1)
- Evaluation of linear versus star-like polymer anti-cancer nanomedicines in mouse models. (2022) (1)
- Predicting PD-1/PD-L1 status in bladder cancer with 18F-FDG PET? (2018) (1)
- Red Blood Cell-Mimicking Hybrid Nanoparticles (2017) (1)
- Correction to Renal-Clearable Ultrasmall Coordination Polymer Nanodots for Chelator-Free 64Cu-Labeling and Imaging-Guided Enhanced Radiotherapy of Cancer. (2018) (1)
- Positron Emission Tomography Imaging of Athero (2013) (0)
- Dual-targeting of tissue factor and CD105 for PET Imaging of Pancreatic Cancer (2016) (0)
- Vector enabled CRISPR gene editing – A revolutionary strategy for targeting the diversity of brain pathologies (2023) (0)
- PET imaging of renal-clearable DNA nanostructures (2016) (0)
- WE‐G‐303‐04: Intrinsically Radiolabeled Nanoparticles: An Emerging Paradigm (2015) (0)
- Production and in vivo PET/CT imaging of the theranostic pair 132/135La (2019) (0)
- Engineering in Translational Medicine: An Introduction (2014) (0)
- Targeting CD38 for theranostics of lymphoma with 89Zr and 177Lu (2019) (0)
- Erratum to: Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence (2013) (0)
- Frozen naphthalocyanine micelles for intestinal imaging (2015) (0)
- Chelator-free 89Zr-labeling of mesoporous silica nanoparticles with superb in vivo radiostability (2015) (0)
- Radio-labeled nano-platforms for imaging, image-guided drug deliveryand theranostics (2016) (0)
- 86/90Y-Labeled Ultrasmall Mesoporous Silica Nanoparticles for Cancer Theranostics (2018) (0)
- Invited Perspective New wine in old bottles: 68Ga-PSMA-11 PET/CT reveals COVID-19 in patients with prostate cancer (2021) (0)
- Editorial: Image-Guided Drug Delivery: State of the Art. (2015) (0)
- Efficient construction of 18F labeled TRC105-Fab based on tetrazine trans-cyclooctene ligation (2014) (0)
- Therapeutic Angiogenesis in Murine Hindlimb Ischemia using 64Cu-labeled Vascular Endothelial Growth Factor-121 PET (2007) (0)
- Amplification of Cerenkov Luminescence Using Semiconducting Polymers for Cancer Theranostics (2023) (0)
- Novel RGD peptide derivatives with enhanced pharmacokinetics for PET imaging (2015) (0)
- Antioxidative neuroprotective role of iron-gallic acid coordination nanoparticles and PET/MR usage in an ischemia stroke model (2019) (0)
- Ultrasmall iron‐gallic acid coordination polymer nanodots with antioxidative neuroprotection for PET/MR imaging‐guided ischemia stroke therapy (2023) (0)
- Redox-Activated Photoacoustic Imaging-Guided Photothermal Therapy with Bioresponsive Polyoxometalate Cluster (2018) (0)
- Quantitative PET of EGFR expression in living mice using 64Cu-labeled anti-EGFR mAb cetuximab (2007) (0)
- Zinc oxide nanowire as a novel platform for optical imaging (2011) (0)
- Small non-coding RNAs as therapeutic agents or targets. (2013) (0)
- PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow (2012) (0)
- 86Y/90Y-labeled ultrasmall porous silica nanoparticles with enhanced pharmacokinetics for cancer theranostics (2022) (0)
- Development and characterization of a hexamodal imaging nanoparticle (2015) (0)
- Nanomaterial-based contrast agents (2023) (0)
- Dual-modality positron emission tomography/optical image-guided photodynamic cancer therapy with PEGylated chlorin e6 nanomicelles (2018) (0)
- PET imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody (2012) (0)
- Multimodal Imaging: Surfactant‐Stripped Frozen Pheophytin Micelles for Multimodal Gut Imaging (Adv. Mater. 38/2016) (2016) (0)
- A 44Sc-labeled cyclic RGD peptide for PET imaging of integrin {alpha}v{beta}3 (2014) (0)
- Labeling of monoclonal antibodies and antibody fragments with radiometals for immunoPET (2015) (0)
- 89Zr-labeled europium-doped Gd2O2S nanoparticles for in vivo lymph node mapping with PET and ɣ-ray excited optical luminescence (2016) (0)
- Hybrid Nanomaterials: An Introduction (2017) (0)
- Astatine-211 for PSMA-targeted α-radiation therapy of micrometastatic prostate cancer: a sustainable approach towards precision oncology. (2023) (0)
- Generation and screening of monoclonal antibodies for immunoPET of EphA2 in cancer (2015) (0)
- High-performance renal imaging with a radiolabeled, non-excretable chimeric fusion protein (2021) (0)
- PET Imaging of Vascular Endothelial Growth Factor Receptor Expression (2006) (0)
- In vivo tumor targeting and dual-modality PET/optical imaging with a yolk/shell structured nanosystem (2015) (0)
- Radioarsenic-labeled mesoporous silica nanoparticles: A new theranostic platform. (2015) (0)
- Reassembly of cancer cell membranes into nanovehicles as a PET-trackable carrier for tumor-targeted theranostics (2018) (0)
- HaloTag as a reporter gene for PET (2013) (0)
- CD146 is a theranostic target in thyroid cancers (2018) (0)
- Molybdenum-based nanoclusters act as antioxidants and ameliorate acute kidney injury in mice (2018) (0)
- Biomedical Applications of Single-Walled Carbon Nanotubes (2011) (0)
- Radiolabeled γ-AApeptides: A new class of PET tracers (2012) (0)
- Theranostic Nanoplatforms for PET Image-Guided Drug Delivery (2017) (0)
- CD146‐targeted nuclear medicine imaging in cancer: State of the art (2023) (0)
- Enhanced γ-ray-excited Radioluminescent of Core-Shell NaGdF4:Eu@NaLnF4 (Ln= Y, Gd, Lu) Nanocrystals by Radiopharmaceutical for Optical Imaging (2019) (0)
- American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2014) e-Century Publishing Corporation. (2013) (0)
- 64Cu-labeled F(ab’)2 fragments of daratumumab for early visualization of CD38-positive lymphoma (2019) (0)
- Epitaxial Growth of Heterostructured Nanoparticles for Biomedical Applications (2017) (0)
- Noninvasive PET imaging of CD38 expression using 89Zr-labeled daratumumab in lymphoma (2018) (0)
- DMT1, a novel PET/MR reporter protein for neural stem cell tracking (2014) (0)
- PET imaging of CD146 expression with a novel 89Zr-labeled monoclonal antibody (2014) (0)
- Theranostics of angiogenic tumors with 86/90Y-labeled antibodies (2019) (0)
- Preparation and in vivo characterization of 51MnCl2 as PET tracer of Ca2+ channel-mediated transport (2017) (0)
- Recent Advances in The Engineering of Silica-Based Core@Shell Structured Hybrid Nanoparticles (2017) (0)
- PET imaging and efficient tumor targeting of labeled single-walled carbon nanotubes (2007) (0)
- PD-L1 - targeted magnetic fluorescent hybrid nanoparticles: Illuminating the path of image-guided cancer immunotherapy. (2023) (0)
- Scaffold, Dendritic and Metal-Assisted Assembly of Collagen-Like Biomaterials (2006) (0)
- PET of abdominal aortic aneurysm (AAA) with a 64Cu-labeled Fab fragment (2014) (0)
- Chelator-Free 89Zr-labeling of Ultra-small WS2/WOx Quantum Dots for PET Imaging (2016) (0)
- Front cover. (2019) (0)
- Non‐Nanoparticle‐Based Dual‐Modality Imaging Agents (2014) (0)
- Highlights from the latest articles in nanomedicine for deep tumor imaging and phototherapy. (2015) (0)
- Fluorescent dye conjugates for optical imaging of cancer (2012) (0)
- Nanoplatforms for cancer targeting and imaging (2012) (0)
- Tumor-targeted, image-guided drug delivery with radiolabeled unimolecular micelles (2014) (0)
- Generalized syntheses of tumor targeted yolk/shell structured multifunctional nanosystems (2015) (0)
- Expression and therapeutic targeting of Trop-2 in treatment resistant prostate cancer. (2023) (0)
- Correction to: Clinical summary of fibroblast activation protein inhibitor‑based radiopharmaceuticals: cancer and beyond (2022) (0)
- Open-shell nanosensitizers for glutathione-responsive sonodynamic therapy of breast cancer (2022) (0)
- Multimodality imaging of kidney function with a renal clearable porphyrin-PEG polymer (2016) (0)
- PET of tumor angiogenesis with a 61/64Cu-labeled F(ab’)2 antibody fragment (2013) (0)
- 15 In Vivo Imaging of Protein-Protein Interactions (2018) (0)
- Effective weight control via an implanted self-powered vagus nerve stimulation device (2018) (0)
- 86/90Y-based theranostics targeting tissue factor in a pancreatic tumor model (2019) (0)
- Molecular Imaging and Therapy of Prostate Cancer (2015) (0)
- PET of acute and chronic inflammation in living mice (2007) (0)
- Red fluorescent ZnO nanoparticle as a novel platform for cancer targeting and imaging (2013) (0)
- American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing Corporation. (2012) (0)
- PET imaging of angiogenesis in murine hindlimb ischemia with a 64Cu-labeled anti-CD105 antibody (2013) (0)
- State-of-the-art of nuclear medicine and molecular imaging in China: after the first 66 years (1956–2022) (2022) (0)
- Quantitative radioimmunoPET of EphA2 expression in xenograft-bearing mice (2007) (0)
- ImmunoPET imaging and radioimmunotherapy of prostate cancer with an anti-Trop2 antibody (2018) (0)
- Invited oral presentations (1997) (0)
- Front Cover: Spherical nucleic acids: Organized nucleotide aggregates as versatile nanomedicine (2022) (0)
- In vivo cell tracking with 52Mn PET: Targetry, Separation, and Applications (2015) (0)
- Optical image-guided therapy of pancreatic cancer with an ultra-small bispecific protein (2023) (0)
- Smart nanoparticles and microbeads for interventional embolization therapy of liver cancer: state of the art (2023) (0)
- Introduction Imaging Gene Expression in Live Cells and Tissues (2011) (0)
- 86/90Y-based theranostics of breast cancer in a preclinical model (2018) (0)
- PET imaging of angiogenesis in a rat myocardial infarction model (2014) (0)
- PET, near-infrared fluorescence, and bioluminescence imaging of breast cancer experimental lung metastasis (2013) (0)
- In Vivo Tumor-Targeted Dual-Modality PET/Optical Imaging with a Yolk/Shell-Structured Silica Nanosystem (2018) (0)
- Editorial: personalized medicine: focusing on translational research. (2013) (0)
- Positron emission tomography and near-infrared fluorescence imaging of CD105 expression in breast cancer with 89Zr-Df-TRC105-800CW (2012) (0)
- Cancer photodynamic therapy with chlorin e6-loaded, goat milk-derived extracellular vesicles: [18F]FDG lights up the way (2022) (0)
- 64Cu-NOTA-YY146: A first-in-class tracer for PET imaging of peripheral artery disease (2015) (0)
- Differential uptake of CD146-specific antibody in solid lung malignancies (2016) (0)
- Chapter 16. Recent Advances in The Engineering of Silica-Based Core@Shell Structured Hybrid Nanoparticles (2016) (0)
- Quantum dot based dual functional probe for optical/PET imaging of tumor VEGFR (2008) (0)
- Dual-modality PET and optical imaging of CD105 expression in breast cancer (2012) (0)
- Integrin α v β 3 -Targeted Optical Imaging with Metal Oxide Nanomaterials: Focusing on Zinc Oxide (2015) (0)
- Radionuclide-based theranostics - a promising strategy for lung cancer. (2023) (0)
- Combined integrin siRNA therapy and radiotherapy of breast cancer. (2006) (0)
- Radiolabeled Vascular Endothelial Growth Factor for Positron Emission Tomography Imaging of Tumor Vasculature (2006) (0)
- PET imaging of tumor integrin expression (2005) (0)
- Review PET imaging of macrophages in cardiovascular diseases (2020) (0)
- ImmunoPET imaging of insulin-like growth factor 1 receptor (IGF-1R) in pancreatic cancer (2016) (0)
- Topic Introduction Photoacoustic Imaging (2011) (0)
- Topic Introduction Imaging Gene Expression in Live Cells and Tissues (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Weibo Cai?
Weibo Cai is affiliated with the following schools:
